131 related articles for article (PubMed ID: 30850479)
1. Innate Control of Tissue-Reparative Human Regulatory T Cells.
Lam AJ; MacDonald KN; Pesenacker AM; Juvet SC; Morishita KA; Bressler B; ; Pan JG; Sidhu SS; Rioux JD; Levings MK
J Immunol; 2019 Apr; 202(8):2195-2209. PubMed ID: 30850479
[TBL] [Abstract][Full Text] [Related]
2. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
[TBL] [Abstract][Full Text] [Related]
3. The ST2
Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
[TBL] [Abstract][Full Text] [Related]
4. Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
Matta BM; Reichenbach DK; Zhang X; Mathews L; Koehn BH; Dwyer GK; Lott JM; Uhl FM; Pfeifer D; Feser CJ; Smith MJ; Liu Q; Zeiser R; Blazar BR; Turnquist HR
Blood; 2016 Jul; 128(3):427-39. PubMed ID: 27222477
[TBL] [Abstract][Full Text] [Related]
5. IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance.
Han JM; Wu D; Denroche HC; Yao Y; Verchere CB; Levings MK
J Immunol; 2015 May; 194(10):4777-83. PubMed ID: 25870243
[TBL] [Abstract][Full Text] [Related]
6. 'Repair' Treg Cells in Tissue Injury.
Zhang C; Li L; Feng K; Fan D; Xue W; Lu J
Cell Physiol Biochem; 2017; 43(6):2155-2169. PubMed ID: 29069643
[TBL] [Abstract][Full Text] [Related]
7. Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8
Chen H; Chen Y; Liu H; Que Y; Zhang X; Zheng F
Front Immunol; 2018; 9():1179. PubMed ID: 29896199
[TBL] [Abstract][Full Text] [Related]
8. Immune- and non-immune-mediated roles of regulatory T-cells during wound healing.
Zaiss DM; Minutti CM; Knipper JA
Immunology; 2019 Jul; 157(3):190-197. PubMed ID: 30866049
[TBL] [Abstract][Full Text] [Related]
9. Kidney GATA3
Sakai R; Ito M; Komai K; Iizuka-Koga M; Matsuo K; Nakayama T; Yoshie O; Amano K; Nishimasu H; Nureki O; Kubo M; Yoshimura A
Cell Mol Immunol; 2021 May; 18(5):1249-1261. PubMed ID: 32917984
[TBL] [Abstract][Full Text] [Related]
10. Foxp3
Dial CF; Tune MK; Doerschuk CM; Mock JR
Am J Respir Cell Mol Biol; 2017 Aug; 57(2):162-173. PubMed ID: 28296468
[TBL] [Abstract][Full Text] [Related]
11. IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.
Stremska ME; Jose S; Sabapathy V; Huang L; Bajwa A; Kinsey GR; Sharma PR; Mohammad S; Rosin DL; Okusa MD; Sharma R
J Am Soc Nephrol; 2017 Sep; 28(9):2681-2693. PubMed ID: 28539382
[TBL] [Abstract][Full Text] [Related]
12. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.
Cao Q; Wang Y; Niu Z; Wang C; Wang R; Zhang Z; Chen T; Wang XM; Li Q; Lee VWS; Huang Q; Tan J; Guo M; Wang YM; Zheng G; Yu D; Alexander SI; Wang H; Harris DCH
J Am Soc Nephrol; 2018 Mar; 29(3):961-976. PubMed ID: 29295873
[TBL] [Abstract][Full Text] [Related]
13. IL-33/ST2 Axis Protects Against Traumatic Brain Injury Through Enhancing the Function of Regulatory T Cells.
Xie D; Miao W; Xu F; Yuan C; Li S; Wang C; Junagade A; Hu X
Front Immunol; 2022; 13():860772. PubMed ID: 35432343
[TBL] [Abstract][Full Text] [Related]
14. IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population.
Nascimento DC; Melo PH; Piñeros AR; Ferreira RG; Colón DF; Donate PB; Castanheira FV; Gozzi A; Czaikoski PG; Niedbala W; Borges MC; Zamboni DS; Liew FY; Cunha FQ; Alves-Filho JC
Nat Commun; 2017 Apr; 8():14919. PubMed ID: 28374774
[TBL] [Abstract][Full Text] [Related]
15. IL-33 increases ST2
Halvorsen EC; Franks SE; Wadsworth BJ; Harbourne BT; Cederberg RA; Steer CA; Martinez-Gonzalez I; Calder J; Lockwood WW; Bennewith KL
Oncoimmunology; 2019; 8(2):e1527497. PubMed ID: 30713780
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
17. The IL-33-ST2-MyD88 axis promotes regulatory T cell proliferation in the murine liver.
Xu L; Li W; Wang X; Zhang L; Qi Q; Dong L; Wei C; Pu Y; Li Y; Zhu J; Zhou S; Liu F; Chen X; Su C
Eur J Immunol; 2018 Aug; 48(8):1302-1307. PubMed ID: 29729112
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of ST2 on regulatory T cells is associated with cancer associated fibroblast-derived IL-33 in laryngeal cancer.
Zhao Y; Sun J; Liang Y; Jiang X; Tang X; Sun Y; Xu C; Wan G; Sun J; Pan C
Pathol Res Pract; 2022 Sep; 237():154023. PubMed ID: 35908385
[TBL] [Abstract][Full Text] [Related]
20. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
